Drug Discovered by Scientists To Cure COVID-19 With Single Dose
Researchers at Monash University in Australia have discovered that a single dose of ivermectin stops the growth of SARS-CoV-2 virus in cell culture with an already existing drug that kills COVID-19 in the laboratory in 48 hours.
The drug, ivermectin, is used to treat head lice and is available worldwide while research is in its infancy, and ivermectin, anti-parasitic drug, has not yet been tested in people infected with COVID-19.
According to the British tabloid Daily Mail, the next step is for scientists to determine the correct human dosage, to ensure that the level used in vitro is safe for humans.
Scientists have warned that it could take at least a month before human trials begin.
“We found that even a single dose could essentially eliminate all of the viral RNA (effectively eliminated all of the genetic material from the virus) by 48 hours and that even at 24 hours there was a really significant reduction,” quotes Daily Mail from Monash Biomedicine Discovery Institute’s Last Friday, Dr. Kylie Wagstaff said.
He added, “At a time when we have a global pandemic and there is no approved treatment, if we had a compound that was already available around the world, it could help people sooner.”
“In reality, it will take some time before a vaccine becomes widely available.”
The study is the work of the Monash Biomedicine Discovery Institute and the Peter Doherty Institute of Infection and Immunity.
Ivermectin was discovered in 1975 and entered medical use in 1981.
It is on the World Health Organization (WHO) list of essential medicines, the safest and most effective medicines that a health system needs.
The wholesale price of the tablets in the developing world is around US $ 0.12 for a course of treatment.
Ivermectin is available worldwide under its trade names Stromectol and Soolantra cream.
It has been used since the 1980s to treat and prevent parasite-related diseases in humans, pets and livestock, and works by paralyzing invertebrate parasites.
Ivermectin is also a second-line treatment for scabies.
The pharmaceutical company that makes Ivermectin, MSD, has also donated the drug to developing countries to treat parasitic diseases of river blindness and elephantiasis for the past 30 years.
When used at the recommended dose, ivermectin is generally the safest. Some of the common side effects include diarrhea, nausea, dizziness and drowsiness.